Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2002-04-08
2009-12-29
Aeder, Sean E (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Reexamination Certificate
active
07638598
ABSTRACT:
Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors and pharmaceutical compositions comprising the same are described. Methods of using such antibodies, peptides, and mimetics in therapeutic, prophylactic, imaging and diagnostic applications are disclosed.
REFERENCES:
patent: 4522918 (1985-06-01), Schlom et al.
patent: 5470571 (1995-11-01), Herlyn et al.
patent: 5480968 (1996-01-01), Kraus et al.
patent: 5677171 (1997-10-01), Hudziak et al.
patent: 5705157 (1998-01-01), Greene
patent: 5720954 (1998-02-01), Hudziak et al.
patent: 5725856 (1998-03-01), Hudziak et al.
patent: 5770195 (1998-06-01), Hudziak et al.
patent: 5772997 (1998-06-01), Hudziak et al.
patent: 5811098 (1998-09-01), Plowman et al.
patent: 5869445 (1999-02-01), Cheever et al.
patent: 6015567 (2000-01-01), Hudziak et al.
patent: 6054297 (2000-04-01), Carter et al.
patent: 6165464 (2000-12-01), Hudziak et al.
patent: 6252050 (2001-06-01), Ashkenazi et al.
patent: 6790614 (2004-09-01), Pippig et al.
patent: 6949245 (2005-09-01), Sliwkowski
patent: 98/17797 (1998-04-01), None
patent: WO 01/00244 (2001-01-01), None
Burgess et al. (J. Cell Biol. 111:2129-2138, 1990).
Lazar et al. (Mol. Cell Biol. 8:1247-1252, 1998).
Park et al (Nature Biotechnology, 2000, 18:194-198).
Saxon et al (JBC, Oct. 1999, 40(1): 28356-28362).
Patel et al (J Pept Res, 1999, 53:68-74).
McBride et al (Journal of Peptide Science, 2000, 6:446-452).
Banner et al., (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF β complex: implications for TNF receptor activation,Cell,73:431-445.
Baselga et al., (1998) Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2
eu overexpressing human breast cancer xenografts,Cancer Res,58:2825-2831.
Brown et al., (1994) Demonstration by two-color flow cytometry that tyrosine kinase activity is required for down-modulation of the oncogenic neu receptor,DNA Cell Biol,13:193-209.
Burgess et al.,. (1996) inSolid phase syntheses of peptidomimetics.(American Chemical Society), ORGN-157.
Capone et al., (1984) Relationship Between Antigen Density and Immunotherapeutic Response Elicited by Monoclonal Antibodies,JNCI,72:673-677.
Carraway et al., (1990) Location of the Epidermal Growth Factor Binding Site on the EGF Receptor. A Resonance Energy Transfer Study,Biochem., 29:8741-8747.
Carter et al., (1992) Humanization of an anti-p185HER2antibody for human cancer therapy,Proceedings of the National Academy of Sciences of the United States of America,89:4285-4289.
Christodoulides et al., (1993) Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein ofNeisseria meningitidis:production of bactericidal antibodies on immunization with a cyclic peptide,Journal of General Microbiology,139:1729-1738.
Cohen et al., (1982) A Native 170,000 Epidermal Growth Factor Receptor-Kinase Complex from Shed Plasma Membrane Vesicles,J. Biol. Chem.,258:1523-1531.
Davies et al., (1995) Antibody VH Domains as Small Recognition Units,Biotechnology,13:475-479.
Davies et al., (1996) Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability,Protein Engineering,9:531-537.
Decanniere et al., (1999) A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops,Structure Fold Des.,7:361-370.
Doherty et al., (1999) TheHER-2
eureceptor tyrosine kinase gene encodes a secreted autoinhibitor,PNAS,96:10869-10874.
Dougall et al., (1994) The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies,Oncogene,9:2109-2123.
Drebin et al. (1986b) Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen,The Proceedings of the National Academy of Science USA,83:9129-9133.
Drebin et al., (1986a) Development of monoclonal antibodies reactive with the product of theneuoncogene,Symp Fundam Cancer Res,38:277-289.
Dumoulin et al., (2002) Single-domain antibody fragments with high conformational stability,Prot. Sci.,11:500-515.
Eck, M. J. & Sprang, S. R. (1989) The structure of tumor necrosis factor-α at 2.6 Å resolution. Implications for receptor binding,J Biol Chem,264:17595-17605.
Eck et al., (1992) The structure of human lymphotoxin (tumor necrosis factor-β) at 1.9- Å resolution,J Biol Chem,267:2119-2122.
Ferguson et al., (2000) Extracellular domains drive homo- but not hetero- dimerization of erbB receptors,Embo J,19:4632-4643.
Fernandez-Pol, (1985) Epidermal Growth Factor Receptor of A431 Cells,Biol. Chem.,260:5003-5011.
Gainer et al., (2000) Gene gun transfection of human glioma and melanoma cell lines with genes encoding human IL-12 and GM-CSF,J. Neuro-Oncol.,47:23-30.
Garrett et al., (1998a) Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor,Nature,394:395-399.
Gill et al., (1989) Calculation of Protein Extinction Coefficients from Amino Acid Sequence Data,Anal. Biochem.,182:319-326.
Goodman et al., (1996) Peptidomimetic building blocks for drug discovery: an overview,Pure Appl. Chem.,68:1303-1308.
Hanessian et al., (1997) Design and synthesis of conformationally constrained amino acids as versatile scaffolds and peptide mimetics,Tetrahedron,53:12789-12854.
Hansen et al., (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill,J. Immunol. Methods,119:203-210.
Heldin, (1995) Dimerization of Cell Surface Receptors in Signal Transduction,Cell,80:213-223.
Jacob et al., (1985) Priming immunization against cholera toxin andE. coliheat-labile toxin by a cholera toxin short peptide-beta-galactosidase hybrid synthesized inE. coli, Embo Journal,4:3339-3343.
Jorissen et al., (2000) Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor,Protein Science,9:310-324.
Koide et al., (2000) DNA Vaccines,J. Pharmacol.,83:167-174.
Koprowski et al., (1985) Expression of the Receptor for Epidermal Growth Factor Correlates with Increased Dosage of Chromosome 7 in Malignant Melanoma,Somatic Cell and Molecular Genetics,11:297-302.
Koskinen et al., (1996) Asymmetric intramolecular cyclopropanation. Synthesis of conformationally constrained aminocyclopropane carboxylic acids,Acta Chem. Scand.,50:323-327.
Kuhn et al., (1997) Fmoc protected peptide mimetic based on a cyclohexane framework and incorporation into angiotensin II,Tetrahedron,53:12497-12504.
Kumagai et al., (2001)The role of distinct p185neuextracellular subdomains for dimerization with the epidermal growth factor receptor and EGF mediated signaling,Proc. Nat. Acad. Sci. USA,98:5526-5531.
Kuriyama et al., (2000) Particle-mediated gene transfer into murine livers using a newly developed gene gun,Gene Ther.,7:1132-1136.
Landgraf et al., (2000) Heregulin Reverses the Oligomerization of HER3,Biochemistry,39:8503-8511.
Lemmon M.A., et al., (1997)Two EGF molecules contribute additively to stabilization of the EGFR dimer,Embo J.,16:281-294.
Li et al., (1997) Homology modeling using simulated annealing of restrained molecular dynamics and conformational search calculations with CONGEN: Application in predicting the three-dimensional structure of murine homeodomain Msx-1,Protein Sci.,6:956-970.
Magliani et al., (1997) Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity,Nat Biotechnol,15:155-158.
Muyldermans et al., (1999) Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies,J. Mol. Recognit.,12:131-140.
Naismith et al., (1998) Modularity in the TNF-receptor family,Trends Biochem Sci,23:74-79.
Naismith et al., (1995) Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor,J Biol Chem,270:13303-13307.
Nayak et al., (1998) B cell responses to a peptide epitope. V. Kinetic regulation of repertoire discrimination and antibody optimization for epi
Berezov Alan
Chen Jinqiu
Greene Mark I.
Liu Qingdu
Murali Ramachandran
Aeder Sean E
The Trustees Of The University Of Pennsylvania
Woodcock & Washburn LLP
LandOfFree
ErbB interface peptidomimetics and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ErbB interface peptidomimetics and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ErbB interface peptidomimetics and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4104698